[Skip to Content]
[Skip to Content Landing]
Article
December 1992

Chronic Epilepsy: Its Prognosis and Management

Author Affiliations

Rochester, Minn

Arch Neurol. 1992;49(12):1225. doi:10.1001/archneur.1992.00530360019005

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

The focus of this book is "chronic" epilepsy, and it is concerned with the 20% to 40% of patients with epilepsy who have recurrent seizures despite treatment with antiepileptic drugs. The topics covered in the 18 chapters include pathophysiology, prognosis, monitoring, imaging, syndromes in children, cognitive hazards, social difficulties, behavioral consequences, strategies of treatment with antiepileptic drugs, management of children, a surgical treatment, epidemiology in developing countries, and genetics. Although most of the authors are associated with well-known medical institutions in London, England, an international approach is provided by including authors from Germany, Ireland, Canada, and the United States.

Clobazam (Frizium), an antiepileptic drug not available in the United States, is discussed in three chapters. Because this drug is available in Canada and Mexico, readers in the United States who practice near the borders of these countries may want to be familiar with its use in adjunctive therapy.

This book

First Page Preview View Large
First page PDF preview
First page PDF preview
×